Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × COVID-19 × regorafenib × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Colorectal Neoplasms 12 Carcinoma, Hepatocellular 4 Liver Neoplasms 3 TAS 102 1 Neoplasms 1 Neoplasm Metastasis 1 Metastatic Colorectal Adenocarcinoma 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Colonic Neoplasms 1 COVID-19 1 Advanced Colorectal Carcinoma 1

Interventions

Surveys and Questionnaires 6 COVID-19 Vaccines 4 Specimen Handling 3 Blood Specimen Collection 3 Surgical Procedures, Operative 2 Pandemic Preparedness 2 Data Collection 2 BNT162 Vaccine 2 2019-nCoV Vaccine mRNA-1273 2 sinovac COVID-19 vaccine 1 regorafenib 1 heterologous prime boost COVID-19 vaccination 1 Sorafenib 1 Serologic Tests 1 Patient Reported Outcome Measures 1 Meopa 1 High-Throughput Nucleotide Sequencing 1 Drug Therapy 1 Colonoscopy 1 Ad26COVS1 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05594147 2023-11-07

ROCURS

Bayer

COVID-19

Data powered by HemOnc (CC BY 4.0) Colophon ⚡